DRREDDY's weekly performance was disappointing, with a return of -1.92%, indicating a decline in stock value. The stock's volatility was moderate at 22.49%, and its Sharpe Ratio of -0.34 suggests that the return was not justified by the level of risk taken. Compared to its peers, DRREDDY underperformed DIVISLAB and SUNPHARMA, but outperformed HINDUNILVR. Overall, the stock was relatively risky this week, with a Max Drawdown of -2.6%.

[Volatility: 22.49%]